Urenco ChemPlants will operate our new Tails Management Facility in the UK, which will deconvert the by-product of enrichment into a more stable form for long term storage for future enrichment or final disposal.
Read moreUrenco Nuclear Stewardship Limited is responsible for the management of nuclear materials, decommissioning and recycling.
Read moreUrenco Stable Isotopes draws on our expertise and capabilities in centrifuge technology to produce stable isotopes for medical, industrial and research applications.
Read moreU-Battery is a conceptual design for a micro modular reactor being developed by a consortium of partners including Urenco.
Read moreOur German enrichment facility is located in Gronau. Its current production capacity is 3,900 tSW/a. Central Technology Group, responsible for enhancing the operation of Urenco’s centrifuge technology, is also based at Urenco Deutschland.
Read moreOur Dutch enrichment facility is located in Almelo. Its current production capacity is 5,200 tSW/a. Our stable isotopes business is also based at Urenco Nederland.
Read moreOur UK enrichment facility is located in Capenhurst. Its current production capacity is 4,600 tSW/a. Our subsidiaries dedicated to overseeing our work in responsible nuclear stewardship are also based at our Capenhurst site.
Read moreOur US enrichment facility is located in Eunice, New Mexico. It is the only operating commercial enrichment facility in the US with a current production capacity of 4,900 tSW/a.
Read more13 September 2021
Urenco joins events in Parliament that focus on why nuclear power is key to achieving the UK’s net zero target by 2050.
Read more10 September 2021
Urenco's Elly Hennelly places third in the Nuclear Institute’s Young Generation Network national final.
Read more08 September 2021
Urenco contributes to the WNA symposium which aims to establish the role of nuclear energy in the transition to a clean and sustainable world.
Read more